Cargando…
Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the COVID-19 pandemic. From the onset of the pandemic, rapid antigen tests have quickly proved themselves to be an accurate and accessible diagnostic platform. The initial (and still most commonly used antigen...
Autores principales: | Hill, Haydon J., Uppal, Timsy, Hau, Derrick, Pandit, Sujata G., Arias-Umana, Jose, Foster, Abigail J., Gorzalski, Andrew, Pflughoeft, Kathryn J., Burnham-Marusich, Amanda R., Reed, Dana E., Gates-Hollingsworth, Marcellene A., Gumbleton, Lynette, Verma, Subhash C., AuCoin, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786212/ https://www.ncbi.nlm.nih.gov/pubmed/36560613 http://dx.doi.org/10.3390/v14122609 |
Ejemplares similares
-
Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021) -
Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023) -
Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023) -
Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015) -
Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
por: Okoye, Nkemakonam C., et al.
Publicado: (2021)